Regulation of PGC-1 Promoter Activity by Protein Kinase B and the Forkhead Transcription Factor FKHR
- 1Center for Tsukuba Advanced Research Alliance, Institute of Applied Biochemistry, University of Tsukuba, Tsukuba, Japan
- 2Department of Oral Pathobiology, Hokkaido University, Sapporo, Japan
Abstract
Peroxisome proliferator–activated receptor-γ coactivator-1 (PGC-1) plays a major role in mediating hepatic gluconeogenesis in response to starvation, during which PGC-1 is induced by the cyclic AMP response element binding protein. Although it is observed that insulin counteracts PGC-1 transcription, the mechanism by which insulin suppresses the transcription of PGC-1 is still unclear. Here, we show that forkhead transcription factor FKHR contributes to mediating the effects of insulin on PGC-1 promoter activity. Reporter assays demonstrate that insulin suppresses the basal PGC-1 promoter activity and that coexpression of protein kinase (PK)-B mimics the effect of insulin in HepG2 cells. Insulin response sequences (IRSs) are addressed in the PGC-1 promoter as the direct target for FKHR in vivo. Coexpression of FKHR stimulates the PGC-1 promoter activity via interaction with the IRSs, while coexpression of FKHR (3A), in which the three putative PKB sites in FKHR are mutated, mainly abolishes the suppressive effect of PKB. Whereas deletion of the IRSs prevents the promoter stimulation by FKHR, that activity is still partially inhibited by insulin. These results indicate that signaling via PKB to FKHR can partly account for the effect of insulin to regulate the PGC-1 promoter activity via the IRSs.
Footnotes
-
Address correspondence and reprint requests to Akiyoshi Fukamizu, Center for Tsukuba Advanced Research Alliance, Institute of Applied Biochemistry, University of Tsukuba, Tennoudai 1-1-1, Tsukuba, Ibaraki 305-8577, Japan. E-mail: akif{at}tara.tsukuba.ac.jp.
Received for publication 12 August 2002 and accepted in revised form 6 December 2002.
ABCD, avidin-biotin conjugate DNA precipitation; CA, constitutively active; ChIP, chromatin immunoprecipitation; CRE, cAMP-response element; CREB, cAMP response element binding protein; DMEM, Dulbecco’s modified Eagle’s medium; DN, dominant negative; FBS, fetal bovine serum; G-6-Pase, glucose-6-phosphatase catalytic-subunit; HNF, hepatocyte nuclear factor; IRS, insulin response sequence; luc, luciferase; PEPCK, phosphoenolpyruvate carboxykinase; PK, protein kinase; PPAR-γ, peroxisome proliferator–activated receptor-γ; PGC-1, PPAR-γ coactivator-1; PI, phosphatidylinositol.
- DIABETES














